MergerLinks Header Logo

Submit Deal

Submit Deal

Cover Image SR ONE LTD
SR ONE LTD

SR ONE LTD

Summary

SR One Capital Management is a leading trans-Atlantic biotech venture capital firm.

Deals Overview

Total Deals15
Valued Deals14
Total Value£ 1.75 B
Avg. Deal Size£ 125 M

Market Context

Senior Management

  • Simeon George

    Simeon George

    CEO

  • Iqbal Mufti

    Iqbal Mufti

    Venture Partner

  • Jake Nunn

    Jake Nunn

    Partner

Sort

08 May 2017|United States|Biotechnology
River Vision Development Corp
Horizon Pharma

Target: RIVER VISION DEVELOPMENT CORP

Bidder: HORIZON PHARMA PLC

1 Service Providers

1 Target

n/a

Value

27 May 2021|United States|Biotechnology
Effector Therapeutics
Locust Walk Acquisition Corp

Target: EFFECTOR THERAPEUTICS

Bidder: LOCUST WALK ACQUISITION CORP

21 Service Providers

7 Target | 14 Bidder

33 Dealmakers

23 Target | 10 Bidder

£ 296 M

Value

29 Nov 2021|United States|Biotechnology
Hotspot Therapeutics
Sofinnova Partners

Target: HOTSPOT THERAPEUTICS

Bidder: SOFINNOVA PARTNERS

10 Service Providers

2 Target | 8 Bidder

11 Dealmakers

3 Target | 8 Bidder

£ 74 M

Value

09 Jun 2022|United States|Biotechnology
Ancora Biotech
Sr One

Target: ANCORA BIOTECH

Bidder: SR ONE LTD

5 Service Providers

2 Target | 3 Bidder

13 Dealmakers

11 Target | 2 Bidder

£ 47 M

Value

08 Jun 2022|United States|Biotechnology
Mineralys Therapeutics
Ra Capital Management

Target: MINERALYS THERAPEUTICS INC

Bidder: RA CAPITAL MANAGEMENT

15 Service Providers

1 Target | 14 Bidder

15 Dealmakers

3 Target | 13 Bidder

£ 94 M

Value

12 Sep 2022|United States|Biotechnology
Nimbus Therapeutics
Sr One

Target: NIMBUS THERAPEUTICS

Bidder: SR ONE LTD

9 Service Providers

2 Target | 7 Bidder

9 Dealmakers

2 Target | 7 Bidder

£ 107 M

Value

13 Oct 2022|United States|Health Care Services
Odyssey Therapeutics
Svb Financial Group

Target: ODYSSEY THERAPEUTICS

Bidder: SVB FINANCIAL GROUP

13 Service Providers

1 Target | 12 Bidder

14 Dealmakers

2 Target | 12 Bidder

£ 152 M

Value

09 Aug 2023|United States|Biotechnology
Adarx Pharmaceuticals
Bain Capital Life Sciences

Target: ADARX PHARMACEUTICALS

Bidder: BAIN CAPITAL LIFE SCIENCES

3 Service Providers

1 Target | 2 Bidder

4 Dealmakers

2 Target | 2 Bidder

£ 156 M

Value

05 Dec 2023|United States|Health Care Services
Odyssey Therapeutics
Alexandria Venture Investments

Target: ODYSSEY THERAPEUTICS

Bidder: ALEXANDRIA VENTURE INVESTMENTS

3 Service Providers

2 Target | 1 Bidder

4 Dealmakers

4 Target

£ 79 M

Value

06 Mar 2024|United States|Biotechnology
ALUMIS
Cormorant Asset Management

Target: ALUMIS

Bidder: CORMORANT ASSET MANAGEMENT

6 Service Providers

3 Target | 3 Bidder

5 Dealmakers

2 Target | 3 Bidder

£ 204 M

Value

07 May 2024|United States|Biotechnology
Zenas Biopharma
Federated Hermes

Target: ZENAS BIOPHARMA

Bidder: FEDERATED HERMES

4 Service Providers

3 Target | 1 Bidder

2 Dealmakers

1 Target | 1 Bidder

£ 160 M

Value

17 Sep 2024|Canada|Biotechnology
Nomic Bio
Amplitude Ventures

Target: NOMIC BIO

Bidder: AMPLITUDE VENTURES

3 Service Providers

2 Target | 1 Bidder

8 Dealmakers

6 Target | 2 Bidder

£ 31 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

Privacy PolicyTerms of ServiceContact UsCookie Preferences

All rights reserved. Copyright © 2025 Datasite